Literature DB >> 8306098

Regional haemodynamic responses to intravenous and intraarterial endothelin-1 and big endothelin-1 in conscious rats.

S M Gardiner1, P A Kemp, T Bennett.   

Abstract

1. In the same chronically-instrumented conscious Long Evans rats, we assessed regional haemodynamic responses to i.v. and i.a. injections of endothelin-1 (ET-1) and big endothelin-1 at doses of 0.05 (n = 4) and 0.5 nmol kg-1 (n = 7). 2. For ET-1, the cardiovascular effects (initial hypotension and tachycardia with transient hindquarters vasodilation, followed by hypertension, bradycardia and renal, mesenteric and hindquarters vasoconstrictions) of i.v. and i.a. injections were not different. 3. Similarly, for big ET-1, the cardiovascular effects (hypertension, bradycardia and renal, mesenteric, and hindquarters vasoconstrictions) of i.v. and i.a. injections were not different. 4. At a dose of 0.5 nmol kg-1, i.v. or i.a., the pressor effects of ET-1 and big ET-1 were not different(area under curve [AUCO-30m.), ET-1 i.v. = 786 +/- 115 mmHg min; ET-1 i.a. = 880 +/- 165 mmHg min;big ET-1 i.v. = 878 +/- 93 mmHg min; big ET-1 i.a. = 833 +/- 103 mmHg min); but ET-1 caused greater renal, and lesser hindquarters, vasoconstrictions than big ET-1 (renal ET-1 i.v., AOC = 1550 +/- 211%min; ET-1 i.a., AOC = 1746 +/- 139% min; big ET-1 i.v., AOC = 1097 +/- 128% min; big ET-1 i.a.,AOC = 1041 +/- 119% min; hindquarters, ET-1 i.v., AOC = 758 +/- 176% min; ET-1 i.a. AOC =787 +/- 184% min; big ET-1 i.v., AOC = 1270 +/- 88% min; big ET-1 i.a., AOC = 1173 +/- 77% min), while the mesenteric vasoconstrictor effects of both peptides were not significantly different (ET-1 i.v.AOC = 1419 +/- 132% min; ET-l i.a., AOC = 1526 +/- 172% min; big ET-1 i.v., AOC = 1099 +/- 166%min; big ET-1 i.a., AOC = 1155 +/- 120% min).5. Under the conditions of our experiments, pulmonary clearance of ET-1, or pulmonary activation of big ET-1, was not apparent from the haemodynamic responses to i.v. and i.a. administration of the peptides. The results are consistent with previous findings indicating that local, rather than systemic,conversion of exogenous big ET-1 to ET-1 is responsible for its regional haemodynamic actions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8306098      PMCID: PMC2175838          DOI: 10.1111/j.1476-5381.1993.tb13997.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation.

Authors:  O F Wagner; H Vierhapper; S Gasic; P Nowotny; W Waldhäusl
Journal:  Eur J Clin Invest       Date:  1992-04       Impact factor: 4.686

2.  Tissue specific distribution, clearance and vascular effects of endothelin in the pig.

Authors:  J Pernow; A Hemsén; J M Lundberg
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

3.  Endothelin produces pulmonary vasoconstriction and systemic vasodilation.

Authors:  H L Lippton; T A Hauth; W R Summer; A L Hyman
Journal:  J Appl Physiol (1985)       Date:  1989-02

4.  Elimination of intravenously injected endothelin-1 from the circulation of the rat.

Authors:  R Shiba; M Yanagisawa; T Miyauchi; Y Ishii; S Kimura; Y Uchiyama; T Masaki; K Goto
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

5.  The fate of radioiodinated endothelin-1 and endothelin-3 in the rat.

Authors:  E Anggård; S Galton; G Rae; R Thomas; L McLoughlin; G de Nucci; J R Vane
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

6.  Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor.

Authors:  G de Nucci; R Thomas; P D'Orleans-Juste; E Antunes; C Walder; T D Warner; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Evidence for a noradrenergic innervation to alpha 1A-adrenoceptors in rat kidney.

Authors:  D R Blue; R L Vimont; D E Clarke
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  Differential uptake of endothelin-1 by the coronary and pulmonary circulations.

Authors:  S Rimar; C N Gillis
Journal:  J Appl Physiol (1985)       Date:  1992-08

9.  Coeliac haemodynamic effects of endothelin-1, endothelin-3, proendothelin-1 [1-38] and proendothelin-3 [1-41] in conscious rats.

Authors:  S M Gardiner; P A Kemp; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

10.  Effects, release and disposal of endothelin-1 in conscious dogs.

Authors:  C Emmeluth; P Bie
Journal:  Acta Physiol Scand       Date:  1992-10
View more
  2 in total

1.  Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver.

Authors:  Peter Johnström; Tim D Fryer; Hugh K Richards; Janet J Maguire; John C Clark; John D Pickard; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2010-02       Impact factor: 8.739

2.  Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivo.

Authors:  Peter Johnström; Tim D Fryer; Hugh K Richards; Neil G Harris; Olivier Barret; John C Clark; John D Pickard; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.